Exhale Launches First-Of-Its-Kind In-Home Service Poised To Help Millions of Asthma and Allergy Sufferers
Revolutionary new patented air-sampling device just one part of comprehensive service that pinpoints exact allergy and asthma triggers inside a home
Exhaleis the only service capable of detecting airborne allergensinside a home. Using a patented air collection unit, state-of-the-art labs and big data, customers are provided personalized information, a dedicated service team and actionable steps so they can better control the allergens that are making them miserable.
More than 50 million people suffer with allergic asthma or allergies and that number continues to grow every year Airborne allergens are a leading culprit: Microscopic and generally harmless, in allergic and asthmatic individuals these allergens can cause coughing, wheezing and other more wide-ranging symptoms, like sleeplessness and irritability
Exhale’s novel service allows the homeowner to plug in the air-sampling device inside their own home and leave it for five days. Air samples are easily returned through the mail and then tested in Exhale’s state-of-the-art labs for 13 commonallergens. Customers get a customized report that details what is potentially problematic in the air they are breathing and what they can do about it. Registered allergy nurses are available to answer questions, discuss results and prioritize steps that can be taken.
Exhale’s breakthrough air-sampling device was developed by biophysicist Julian Gordon. It combines the same ionic propulsion used by NASA with cutting-edge molecular biology that hospitals use to detect disease in blood and urine samples. Exhale collects microscopic allergens from 1 million liters of air, and is more powerful than any available commercial technology. Dr. Gordon calls Exhale, “a completely new dimension in self-managing one’s environment. It is the ultimate in personalized medicine.”
Exhale founder and CEO Prasanthi Gandhi is a serial entrepreneur and a mom of two children affected by allergies and asthma. She is also a life-long allergy and asthma sufferer herself. Three years ago, she asked herself the question that led to the creation of Exhale: “Why hasn't the prevention of asthma and allergies changed significantly in the past 25 years?” She was determined to do things differently for her own children, and the millions of other sufferers out there. After years of scientific and clinical research with co-founder Julian, she knew it was possible.
Exhale has been validated by leading allergists, researchers and The University of Chicago and Argonne National Labs.
Packages start at $297. Order it. Plug it in. Send it back. Get results. It’s that easy. 1
For more information:
Press Contact: Kathleen O’Hara, 630.251.3215 kohara@inspirotec
1
About the Exhale Team:
Prasanthi Gandhi – Co-Founder and Chief Exhaler
A compassionate and energetic business leader, Prasanthi has an MBA from Northwestern University’s Kellogg School of Management and an MPH (Master’s in Public Health) from Columbia University’s Mailman School of Public Health. She has more than a decade of experience leading both startup ventures and established product innovation organizations. Exhale is personally meaningful to Prasanthi because she is a life-long asthma and allergy sufferer. “I want people dealing with allergies and asthma to have access to tools and knowledge that empower them to live their healthiest, best lives,” Prasanthi explains. “That’s what Exhale is all about.”
Julian Gordon – Chief Scientific Officer
A world-renowned serial inventor who has made groundbreaking contributions to multiple fields of science. His group at Abbott Labs was responsible for developing lateral flow immunoassay technology, which led to the first home pregnancy tests. Prior to Abbott Labs, Julian’s group at Novartis (then CIBA-GEIGY) was responsible for inventing the Western Blot, an important method used today in molecular biology, biochemistry and immunogenetics for the characterization and detection of proteins. Julian is passionate about using evidence-based data to prevent human suffering.
Dr. Paul Detjen – Medical Director
A practicing allergist-immunologist for more than 20 years, he earned his medical degree from Washington University School of Medicine in St. Louis and completed his residency and fellowship at Northwestern University Feinberg School of Medicine. Dr. Detjen is affiliated with multiple hospitals in the
Chicago area, including NorthShore Evanston Hospital and Northwestern Memorial Hospital. He has helped thousands of families address allergies and asthma so they can live healthier, better lives.
1Dr. Priya Bansal – Medical Advisor
Dr. Bansal completed a six-year joint BS/MD program at Penn State University and Thomas Jefferson Medical School. She completed her residency in Internal Medicine and Pediatrics at University of Illinois in Chicago and was board certified in both specialties. She then became board certified in Allergy and Immunology after her
fellowship at Rush University Medical Center. Dr. Bansal served as President for the Illinois Society of Allergy and is currently a RSLAAIS governor for the American Academy of Allergy, Asthma, and Immunology (AAAAI).
###